---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-321176"
form_type: "8-K"
ticker: "TPST"
cik: "0001544227"
company_name: "Tempest Therapeutics, Inc."
filed_at: "2026-07-28T20:50:54+00:00"
generated_at: "2026-07-28T20:52:06.827383+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Tempest Therapeutics adjourns special meeting due to insufficient votes for governance amendment

## Summary
- Special meeting on July 27, 2026 adjourned; proposal to replace supermajority voting and allow written consent lacked sufficient votes.
- Proposal requires 75% affirmative vote; only 67.7% of shares present, but votes not enough to approve.
- Meeting reconvenes August 17, 2026; previously submitted proxies remain valid unless revoked.
- Company engaged Sodali & Co. to assist with obtaining adequate votes for the proposal.
- Record date remains May 28, 2026; no changes to the proposal.

## SEC filing metadata
- accession: 0001193125-26-321176
- form_type: 8-K
- ticker: TPST
- cik: 0001544227
- company_name: Tempest Therapeutics, Inc.
- filed_at: 2026-07-28T20:50:54+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07, 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1544227/000119312526321176/0001193125-26-321176-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1544227/000119312526321176/d105624d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-321176
- JSON: https://secwatch.observer/filing/0001193125-26-321176.json
- Plain text: https://secwatch.observer/filing/0001193125-26-321176.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.